METTL3 in esophageal cancer: Current insights into molecular mechanisms, subtype heterogeneity and targeted therapy prospects (Review)

International Journal of Oncology · Published 2026-04-21 · DOI 10.3892/ijo.2026.5884

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.3892/ijo.2026.5884

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• PDLIM2 acts as a central regulator of ubiquitination, immune signaling, and mitochondrial metabolism in lung cancer suppression (Review) · International Journal of Oncology · 2026 · Same journal
• The role of deubiquitinating enzymes and their inhibitors in esophageal carcinoma (Review) · International Journal of Oncology · 2026 · Same journal
• Smoking promotes colorectal cancer via the CKAP2L/AREG axis · International Journal of Oncology · 2026 · Same journal
• [Retracted] Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells · International Journal of Oncology · 2026 · Same journal
• Biomarkers for oesophageal squamous cell carcinoma and the role of HPV: Multi‑omics approaches and current evidence (Review) · International Journal of Oncology · 2026 · Same journal
• Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil‑mediated promotion of DNA damage‑driven cytotoxicity · International Journal of Oncology · 2026 · Same journal
• Glycolysis‑driven immunosuppression in gastric cancer: Metabolic crosstalk between tumor cells and the immune microenvironment (Review) · International Journal of Oncology · 2026 · Same journal
• Research advances in aptamers in the diagnosis and treatment of breast cancer (Review) · International Journal of Oncology · 2026 · Same journal
• Radiotherapy resistance in glioblastoma: Mechanistic insights and novel therapeutic approaches (Review) · International Journal of Oncology · 2026 · Same journal
• [Retracted] Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase‑2 · International Journal of Oncology · 2026 · Same journal